ArticleCell cycle (Georgetown, Tex.)2023

CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan.

Joshua Blume et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.